Best Shot First: Two ICIs Upfront for Advanced Melanoma Best Shot First: Two ICIs Upfront for Advanced Melanoma

With no biomarkers to say who can safely delay dual therapy, an editorialist said that two checkpoint inhibitors in the first line might be"prudent."Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news